Brian Dorsey, Chief Development Officer at APRICUS BIOSCIENCES, INC. (APRI), bought 10,000 shares at $1.05 ($11K) on 2014-12-29, disclosed to the SEC on 2014-12-30.
Open-market purchase of $10k APRI by Chief Development Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SPRY | SELL | 2024-08-21 | $750K | — | Filing → |
| SPRY | SELL | 2024-08-15 | $390K | — | Filing → |
| SOMX | SELL | 2012-01-04 | $4K | — | Filing → |